GSA Capital Partners’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31,537
| Closed | -$863K | – | 1959 |
|
|
2025
Q1 | $863K | Buy |
31,537
+1,997
| +7% | +$54.6K | 0.08% | 437 |
|
|
2024
Q4 | $1.19M | Buy |
29,540
+8,058
| +38% | +$324K | 0.09% | 296 |
|
|
2024
Q3 | $1.02M | Sell |
21,482
-6,051
| -22% | -$286K | 0.08% | 459 |
|
|
2024
Q2 | $822K | Buy |
27,533
+15,888
| +136% | +$474K | 0.06% | 639 |
|
|
2024
Q1 | $468K | Sell |
11,645
-10,931
| -48% | -$439K | 0.04% | 923 |
|
|
2023
Q4 | $575K | Sell |
22,576
-28,512
| -56% | -$726K | 0.05% | 705 |
|
|
2023
Q3 | $710K | Buy |
51,088
+29,904
| +141% | +$416K | 0.06% | 583 |
|
|
2023
Q2 | $487K | Buy |
+21,184
| New | +$487K | 0.05% | 758 |
|
|
2023
Q1 | – | Sell |
-13,301
| Closed | -$332K | – | 1713 |
|
|
2022
Q4 | $332K | Buy |
13,301
+1,293
| +11% | +$32.3K | 0.04% | 869 |
|
|
2022
Q3 | $261K | Sell |
12,008
-17,914
| -60% | -$389K | 0.03% | 1022 |
|
|
2022
Q2 | $589K | Buy |
29,922
+23,920
| +399% | +$471K | 0.09% | 393 |
|
|
2022
Q1 | $254K | Sell |
6,002
-21,670
| -78% | -$917K | 0.03% | 1019 |
|
|
2021
Q4 | $1.76M | Buy |
+27,672
| New | +$1.76M | 0.22% | 41 |
|